World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 27 May 2013
Main ID:  NTR867
Date of registration: 08/01/2007
Primary sponsor: Academic Medical Center (AMC), Department of Gastroenterology
Public title: ETMI vs. standard video endoscopy for the detection of early neoplasia in patients with low-grade dysplasia in a Barrett's esophagus: a multi-center randomized cross-over controlled study
Scientific title: ETMI vs. standard video endoscopy for the detection of early neoplasia in patients with low-grade dysplasia in a Barrett's esophagus: a multi-center randomized cross-over controlled study - GETMI
Date of first enrolment: 1/1/2007
Target sample size: 96
Recruitment status: recruiting
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=867
Study type:  intervention
Study design:  Randomised: Yes; Masking: None; Control: Not applicable; Group: Crossover; Type: -  
Countries of recruitment
The Netherlands
Contacts
Name: J.J.G.H.M.  Bergman
Address:  Academic Medical Center Bldg. C2-210, Meibergdreef 1105 AZ Amsterdam The Netherlands
Telephone: +31 (0)20 5669111
Email: j.j.bergman@amc.uva.nl
Affiliation: 
Name: J.J.G.H.M.  Bergman
Address:  Academic Medical Center Bldg. C2-210, Meibergdreef 1105 AZ Amsterdam The Netherlands
Telephone: +31 (0)20 5669111
Email: j.j.bergman@amc.uva.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Barrett's esophagus patients with low-grade dyplasia comfirmed by two expert GI pathologists;
2. Written informed consent

Exclusion criteria: 1. Presence of active erosive esophagitis grade A according to the Los Angles classification of erosive esophagitis;
2. Presence of conditions precluding histological sampling of the esophagus (e.g. esophageal varices, coagulation disorders, anticoagulant therapy);
3. < 18 years


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Barrett's esophagus

Intervention(s)
ETMI-gastroscopy and standard video gastroscopy
Primary Outcome(s)
1. Number of patients with early neoplasia detected with ETMI or SVE;
2. Number of lesions with early neoplasia detected with ETMI and SVE.
Secondary Outcome(s)
1. Number of early neoplastic lesions detected with AFI only;
2. Reduction of false positives findings after detailed NBI evaluation.
Secondary ID(s)
ISRCTN91816824
N/A
Source(s) of Monetary Support
ZON-MW, The Netherlands Organization for Health Research and Development
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history